LBX pharmacy chain joint stock (603883.SH) stated in an institutional investor exchange event that it is one of the enterprises with the widest coverage of China's pharmaceutical retail market, and its broad coverage provides the company with extensive development opportunities and great potential for improving its market share. By the end of 2023, the company's chain network (excluding alliances) had covered 18 provincial-level markets and more than 150 cities at or above the prefecture level, with a total of 13,574 stores nationwide. The 18 provinces already covered by the company account for 3/4 of the pharmaceutical retail market in China. The company plans to focus on its advantageous provincial markets and actively expand into emerging markets. Specifically, the company will focus on expanding its network of stores in 11 priority provinces, deepen its presence in its most advantageous markets, and actively explore emerging markets.